Browsing "1. Journal Papers" by Author : Park, Hee-Kwon
Showing results 1 to 8 of 8
This table browses all dspace content
| Issue Date | Title | Journal Title |
| 2025 | Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined Source | JOURNAL OF STROKE |
| 2026 | Comparison of clopidogrel-based antiplatelet therapy versus warfarin as secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial | CONTEMPORARY CLINICAL TRIALS |
| 2026 | Design and rationale of the clinical trial to obtain the highest efficacy of dual antiplatelet therapy after carotid artery stenting in high bleeding risk patients (CHET): A multicenter, randomized, open-label, superiority trial | AMERICAN HEART JOURNAL |
| 2025 | Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke
| JOURNAL OF STROKE |
| 2025 | Exploring the efficacy and safety of dual antiplatelet therapy in patients with embolic stroke of undetermined source according to stroke risk stratification: Propensity-score matched analysis
| JOURNAL OF STROKE & CEREBROVASCULAR DISEASES |
| 2025 | Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial
| JAMA NETWORK OPEN |
| 2025 | Supracardiac Atherosclerotic Lesions in Embolic Stroke of Undetermined Source: Predicting Stroke Recurrence and Enhancing Secondary Prevention Strategies
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2025 | Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal A Multi-Center, Open-Label, Single-Arm Trial
| JOURNAL OF STROKE |
